Bird Flu Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
Conditions:   Influenza A Virus Infection;   Influenza A;   Influenza Epidemic;   Influenza H5N1 Intervention:   Biological: GamFluVac Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2018 Category: Research Source Type: clinical trials